100 million vulnerable patients worldwide are suffering the limitations of a urinary catheter design that is almost unchanged since the 1930's. Limitations that result far too often in infection, blockage, pain and distress for patients
THE Flume CATHETER REVOLUTION
The new patented 'Flume' design aims to revolutionise the experience of catheter patients
BYE BYE BLOCKAGES
The first results of lab trials has validated a major benefit in time to blockage - more than twice that of the market leader.
Less blockages means less leakage - an issue suffered by 45% of catheter patients.
Infection reduction is anticipated from Flume's innovative balloon design, protecting the sensitive bladder wall from the hard catheter drainage tube while enabling the bladder to drain fully and thereby avoiding the Foley's sump of festering urine.
From concept to reality
Having successfully completed laboratory trials at Bristol Urological Institute (BUI), our next step is to freeze the design, and prepare to submit to independent testing under EN1616 as part of seeking CE mark regulatory approval. At the same time we are delighted that Prof. Marcus Drake at BUI is taking the lead as Clinical Investigator and has submitted a grant application for 'first in human' clinical trials across 3 centres. Let us know if you would like to keep in touch with our progress...
AND YOU CAN HELP TOO!
WHETHER A PATIENT...
We have listened to the experience of 100's of patients so far, and it would be hugely valuable if you are a patient too and can add what is most important that we address from your experience. That way you will help us make sure we deliver the best possible solution with the new Flume Catheter
OR A Carer...
We have gathered invaluable frontline experience from over 120 Community Nurses that care directly for 2,500+ patients with indwelling catheters. If you could add your experience you could make sure we address what matters. A short survey monkey survey of just 10 questions that could make a real difference. Follow the link now.......